NIH-funded research R37 grant

Understanding and predicting cancer-related fatigue during chemotherapy

Official title: An Investigation of the Molecular Mechanisms for and Prediction of the Severity of Cancer Chemotherapy-Related Fatigue Using a Multi-staged Integrated Omics Approach

Funded at University of California, San Francisco · NIH-10789801 · Data updated 2026-11-12

This study is looking into why some cancer patients feel really tired during treatment and aims to create a tool that helps doctors spot those who might struggle the most with fatigue, so they can offer personalized tips to help manage it and improve their overall well-being.

More Chemotherapy research and trials

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startJuly 3, 2019
Project endJune 30, 2026
Funding year2024
Award (this year)$624,441
NIH project number4R37CA233774-06
Project IDNIH-10789801 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are cancer patients currently receiving chemotherapy or radiation therapy who are experiencing or at risk of severe fatigue.

Less likely to help

Patients who are not undergoing chemotherapy or radiation therapy may not benefit from this research.

What this research studies

This research investigates the causes and severity of cancer-related fatigue (CRF), a common and debilitating symptom experienced by cancer patients undergoing treatment. By utilizing a multi-staged integrated omics approach, the study aims to develop a risk prediction model that can identify patients at high risk for severe CRF. This model will help clinicians provide tailored recommendations for managing fatigue, such as exercise interventions, and improve overall patient quality of life. The research also seeks to uncover the biological mechanisms behind CRF, potentially leading to new therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to better management strategies for cancer-related fatigue, enhancing the quality of life for patients undergoing chemotherapy.

How similar studies have gone: Previous research has indicated that understanding the mechanisms of cancer-related fatigue can lead to improved management strategies, suggesting that this approach has potential for success.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Kober, Kord Michael — University of California, San Francisco
  • Study coordinator: Kober, Kord Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.